Bomedemstat
Imago BioSciences
[]
$imgo imago biosciences presents positive data from ongoing phase 2 study of bomedemstat in advanced myelofibrosis at eha 2022 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft